Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-29

Clinical Trial Update: A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Granexin Gel for diabetic foot ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granexin Gel

Snippet

Sponsor: Xequel Bio, Inc. | Conditions: Diabetic Foot Ulcers | Phase 3 | Status: TERMINATED